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        MyD88 (myeloid diff  erentiation primary re-
sponse gene 88) is the founding member of a 
family of mammalian cytosolic adaptor proteins 
distinguished by a C-terminal Toll-interleukin 1 
receptor (TIR) domain. The four best-studied 
members of the MyD88 family all play promi-
nent roles in innate immunity. MyD88 is a 
critical intermediary in signaling through in-
terleukin-1 receptors, interleukin-18 receptor, 
and most Toll-like receptors (TLRs), except for 
TLR3 (  1, 2  ). MyD88-2, which is also known 
as TIR domain  –  containing adaptor protein 
(TIRAP) or MyD88 adaptor  –  like (MAL), is 
required for TLR4- and MyD88-dependent 
responses and for signaling via TLR2 (  3  –  5  ). 
MyD88-3, which is commonly called TIR do-
main  –  containing adaptor inducing interferon-
      (TRIF) or TIR domain  –  containing adaptor 
molecule-1 (TICAM-1), mediates responses to 
ligation of TLR3, as well as those responses to 
ligation of TLR4 that are MyD88-independent 
(  6  –  8  ). MyD88-4, which is also called TRIF-
related adaptor molecule (TRAM) or TIR-
domain containing protein (TIRP), shares with 
MyD88-3 the mediation of  TLR4-dependent, 
but MyD88-independent responses (  9  –  11  ). 
  In contrast, the function of MyD88-5, which 
is also called sterile       and HEAT/Armadillo 
motifs containing protein (SARM), remains a 
mystery (  12  ). That the function of MyD88-5 is 
fundamental is suggested by its high degree of 
conservation among fl  y, worm, and mammals. 
That MyD88-5 plays a diff  erent role than the 
other members of the MyD88 family is sug-
gested by its 7  –  8 N-terminal HEAT/Armadillo 
repeats and two sterile       motif (SAM) domains, 
structures typically involved in protein  –  protein 
interactions in cytoskeletal regulation and intra-
cellular signaling (  13  –  15  ). 
  In   Caenorhabditis elegans  , the MyD88-5 ho-
mologue TIR-1 is the sole cytoplasmic protein 
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  The innate immune system relies on evolutionally conserved Toll-like receptors (TLRs) to 
recognize diverse microbial molecular structures. Most TLRs depend on a family of adaptor 
proteins termed MyD88s to transduce their signals. Critical roles of MyD88-1  –  4 in host 
defense were demonstrated by defective immune responses in knockout mice. In contrast, 
the sites of expression and functions of vertebrate MyD88-5 have remained elusive. We 
show that MyD88-5 is distinct from other MyD88s in that MyD88-5 is preferentially 
expressed in neurons, colocalizes in part with mitochondria and JNK3, and regulates neuronal 
death. We prepared MyD88-5/GFP transgenic mice via a bacterial artifi  cial chromosome 
to preserve its endogenous expression pattern. MyD88-5/GFP was detected chiefl  y in the 
brain, where it associated with punctate structures within neurons and copurifi  ed in part 
with mitochondria. In vitro, MyD88-5 coimmunoprecipitated with JNK3 and recruited 
JNK3 from cytosol to mitochondria. Hippocampal neurons from MyD88-5  –  defi  cient mice 
were protected from death after deprivation of oxygen and glucose. In contrast, MyD88-5  – 
null macrophages behaved like wild-type cells in their response to microbial products. 
Thus, MyD88-5 appears unique among MyD88s in functioning to mediate stress-induced 
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each of which was independently described during our analysis. 
However, when we searched SMART and PFAM databases, 
which are based on position-specifi  c scoring matrix systems, 
we identifi  ed MyD88-5 as a protein with two SAM domains 
fl  anked by a C-terminal TIR domain and N-terminal HEAT/
Armadillo repeats (Fig. S1 A, available at http://www.jem
.org/cgi/content/full/jem.20070868/DC1). While this func-
tional characterization was in progress, cloning of MyD88-5 
was reported (  12  ). MyD88-5 homologues are found in fl  ies, 
worms, fi  sh, and mammals. In its phylogenetic context (Fig. 
S1 B), there is a deep division of MyD88-5 homologues of 
mammals,   Drosophila melanogaster   (Ect-4) (  31  ), and   C. elegans   
(TIR-1) from other TIRPs, suggesting that the functions of 
MyD88-5s may diff  er from those of the IL-1/18 receptor 
family, the TLRs, the Tolls, and the other MyD88s. 
  MyD88-5 is expressed mainly in brain 
  Northern blot analysis using part of the cloned mouse MyD88-5 
cDNA containing both SAM domains and the TIR domain 
as a probe revealed the expected     7.4-kb transcript in brain, 
but not in heart, kidney, liver, lung, skeletal muscle, spleen, or 
thymus (  Fig. 1 A  ), in contrast to the study by Mink et al. (  12  ).   
An additional transcript of shorter size (    4 kb) may represent 
a splice variant, but antibody raised against full-length recom-
binant mouse MyD88-5 detected only one polypeptide in 
mouse brain and in MyD88-5  –  transfected COS-1 cells, and 
its apparent molecular weight (79 kD) matched that expected 
for the full-length protein (  Fig. 1 B  ). 
  Quantitative real-time RT-PCR (qRT-PCR) confi  rmed 
the preferential expression of MyD88-5 mRNA in brain of 
mouse (  Fig. 1 C  ) and human (  Fig. 1 D  ). MyD88-5 transcripts 
were also detected in mouse spleen and lymph nodes, but not 
in thymus (  Fig. 1 C  ). In human peripheral blood, lympho-
cyte-enriched populations expressed MyD88-5 mRNA, 
whereas monocyte- and PMN-enriched populations did not 
(  Fig. 1 D  ). Focusing on brain as the richest source of MyD88-5, 
we compared transcript levels in diff  erent anatomic regions. 
Expression levels were comparable across the organ (  Fig. 1 E  ). 
During embryonic development of the mouse, MyD88-5 
expression increased gradually in the brain, peaking on 
day 18, which is a period of massive neuronal proliferation 
and programmed cell death (  32  ). Levels fell threefold after 
birth (  Fig. 1 F  ). 
  MyD88-5 is expressed in neurons 
  Next, we sought to identify the cell types responsible for the 
relatively high level of MyD88-5 expression in brain. De-
spite extensive eff  orts to raise antibodies in rabbits and chick-
ens against recombinant mouse and human MyD88-5, the 
resulting reagents suffi   ced only for Western blots, not for 
immunoprecipitation, immunohistochemistry, or fl  ow cy-
tometry. As an alternative strategy, we generated enhanced 
GFP-tagged MyD88-5 transgenic lines of mice using a BAC. 
RP23-399H5, which is a 196-kb BAC clone, included an ex-
tra 156 kb of mouse genomic DNA upstream of the   MyD88-5   
translation start site, as well as 14 kb after the stop codon. 
with a TIR domain. TIR-1 was hypothesized to mediate signal-
ing from TOL-1, which is the only TLR homologue. Indeed, 
knockdown of   tir-1   shortened the lifespan of worms feeding 
on   Drechmeria coniospora  ,   Serratia marcescens   (  16  ),   Pseudomonas 
  aeruginosa,   and   Enterococcus faecalis   (  17  ). However, this eff  ect 
was independent of TOL-1 (  16  ). Thus, rather than mediat-
ing signaling from TOL-1, TIR-1 may have controlled re-
cognition of environmental cues derived from the pathogenic 
bacteria. Consistent with the latter interpretation,   tir-1   mutants 
displayed bilateral, symmetric expression of an olfactory recep-
tor candidate gene,   str-2,   in both of their olfactory neurons (  18  ). 
In contrast, in wild-type worms, only one of the two neurons 
expresses this gene (  19  –  21  ); the asymmetry may contribute to 
the worm  ’  s ability to mount an adaptive directional response to 
environmental cues. Epistasis analysis suggested that TIR-1 
may infl  uence olfactory neuronal development at a step be-
tween UNC-43, a calmodulin-dependent protein kinase II 
homologue, and NSY-1, a homologue of human ASK1, which 
is a MAP kinase kinase kinase (  18, 22  ). 
  In mammals, the roles of MyD88-1  –  4 were demonstrated 
by their ability to activate NF-     B or the IFN-      promoter 
when overexpressed and by a loss of TLR-mediated function 
when individual MyD88 members were target-deleted (  6, 
10, 11, 23, 24  ). In contrast, overexpression of MyD88-5 in 
HEK293 cells did not induce expression of NF-     B  –   or IFN-       – 
regulated reporter genes (  17, 25  ), and MyD88-5 knockout 
mice have not previously been described. Recently, Carty et al. 
(  26  ) suggested that MyD88-5 might serve as a negative regu-
lator of TRIF-dependent TLR signaling based primarily on 
overexpression or siRNA-mediated suppression of MyD88-5 
in HEK 293 cells. It is not clear, however, whether myeloid 
cells express MyD88-5. 
  To learn the role of mammalian MyD88-5, we cloned 
the mouse and human genes, raised antibodies to the re-
combinant proteins, and performed expression, transfection, 
colocalization, coimmunoprecipitation, bacterial artifi  cial 
chromosome (BAC) transgenic, and knockout mouse studies. 
These approaches revealed that human and mouse myeloid 
cells expressed little MyD88-5. Mouse macrophages re-
sponded to poly(I:C) and LPS normally in the absence of the 
MyD88-5 gene. In contrast, MyD88-5 is expressed primarily 
in neurons, where it associates with mitochondria, microtu-
bules, and JNK3 and regulates neuronal death during depri-
vation of oxygen and glucose. 
    RESULTS   
  MyD88-5 is evolutionarily conserved 
  Proteins with a TIR domain are found throughout the plant 
and animal kingdoms, with or without transmembrane do-
mains; MyD88 is an example of the latter subset (  27  –  29  ). 
Shortly after it was found that not all TLR-dependent innate 
immune responses depend on MyD88 (  30  ), we conducted a 
bioinformatic search for additional proteins with TIR do-
mains that like MyD88, but in contrast to TLRs, were pre-
dicted to be cytoplasmic. Sequence homology led only to 
identifi  cation of MyD88-2 (  3  –  5, 24  ), -3 (  6, 8  ), and -4 (  9, 11  ), JEM VOL. 204, September 3, 2007 
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Therefore, the expression of the transgene was expected to 
faithfully refl  ect the expression of the endogenous gene (  33  ). 
As schematized in   Fig. 2 A  , we engineered   Myd88-5   to be ex-
pressed with a C-terminal GFP fusion construct. Southern 
blot of a KpnI restriction enzyme digest (  Fig. 2 B  ) showed 
the integrated DNA in a band migrating at 3.9 kb and the 
endogenous gene at 2.8 kb.   Founders with one integrated 
copy of the BAC plasmid did not show a detectable level of 
GFP expression by fl  uorescence or anti-GFP Western blot. 
Therefore, we established transgenic lines from founders ex-
pressing 4  –  12 copies of the transgene, but for unknown 
reasons, only mice with 4 copies of the transgene produced 
F1 progeny. Western blot analysis with anti  –  MyD88-5 anti-
body detected both the MyD88-5/GFP fusion protein and 
the endogenous MyD88-5 in the brains of three indepen-
dent founders, as well as in three independent F1 generations 
derived from another set of founders, and Western blot anal-
ysis with anti-GFP antibody confi  rmed the expression of 
the fusion protein in the brain (  Fig. 2 C  ). FACS analysis de-
tected no expression of MyD88-5/GFP in thymocytes or 
CD11b      splenocytes (macrophages) and low-level expres-
sion in CD3      splenocytes (Fig. S2, available at http://www
.jem.org/cgi/content/full/jem.20070868/DC1), which is con-
sistent with the expression pattern of endogenous MyD88-5 
transcripts (  Fig. 1 C  ). 
  Next, using anti-GFP antibody for immunohistochemistry, 
we compared brain sections from transgenic mice and their 
nontransgenic littermates. Expression of GFP was widespread 
throughout the brain of the transgenics (  Fig. 2 D  ), which is 
consistent with the widespread cerebral and cerebellar expres-
sion of endogenous MyD88-5 transcripts (  Fig. 1 E  ). 
  In a transgenic mouse that had integrated 12 copies of the 
transgene, the fusion protein was readily detected via the in-
trinsic fl  uorescence of GFP. Confocal microscopic images of 
GFP fl  uorescence obtained without antibody amplifi  cation 
showed expression solely in neurons and not in oligodendro-
cytes, astrocytes, microglia, meningeal lining cells, or cells 
of the vasculature. Expression was particularly robust in the 
pyramidal cells of the hippocampus (CA1-3 cells) and Purkinje 
cells of the cerebellum. The MyD88-5 fusion protein appeared 
to be exclusively cytoplasmic in localization and partly punctate 
in distribution (  Fig. 2 E  ). 
  MyD88-5 is associated with mitochondria 
  To identify the punctate structures with which much of the 
MyD88-5 fusion protein appeared to associate, we trans-
fected COS-1 cells with a MyD88-5/GFP fusion construct. 
The cells were costained with anti  –       -adaptin for visualization 
of Golgi, anti-tubulin for microtubules, or MitoTracker Red 
CMXRos for mitochondria. MyD88-5/GFP fusion protein 
strongly colocalized with mitochondria and partly colocalized 
with microtubules (  Fig. 3 A  ), structures along which mito-
chondria move (  34  ).   Confocal images suggested that MyD88-5 
did not reside within the mitochondrial matrix, where the 
MitoTracker Red CMXRos dye accumulates, but instead was 
localized outside the mitochondrial matrix (  Fig. 3 B  , right), 
This confi  guration was expected to include the full comple-
ment of endogenous promoter/enhancer sequences and to 
allow for physiologic generation of alternative splice variants. 
Figure 1.  MyD88-5 is expressed mainly in brain, but not in mye  loid 
cells. (A) Northern blot analysis of MyD88-5 expression in mouse 
tissues using the two SAM domains and part of the TIR domain (1,200–
1,816 bp) as a probe. An actin probe was used as a loading control. 
(B) Western blot with chicken antibody raised against full-length recom-
binant mouse MyD88-5 reveals a 79-kD polypeptide in mouse brain 
(left lane) and in COS-1 cells transfected with a Flag-tagged MyD88-5 
construct (right lane, fi  lled arrowhead), but not in vector-transfected COS-1 
cells (center lane). The open arrowhead indicates a nonspecifi  c band. 
(C) Relative quantitation of MyD88-5 transcripts in mouse tissues and 
cells. Expression was highest in brain and moderate in lymph node (LN) 
and purifi  ed splenic T cells, but was barely detectable in splenic popula-
tions (chiefl  y macrophages) depleted of T and B cells (T- B-). Data are 
quantitative real-time PCR results normalized to mouse GAPDH and 
expressed as the percentage of the level in brain. One of three independent 
experiments is shown. (D) Relative quantitation of MyD88-5 transcripts in 
human tissues and cells. Expression of human MyD88-5 mRNA is highest 
in brain and detectable in lymphocytes (L). Polymorphonuclear leukocytes 
(PMN), monocytes (M), and lymphocytes were purifi  ed from human blood. 
Data are expressed as in C for one of three independent experiments. 
(E) MyD88-5 expression in various anatomic regions of adult mouse brain. 
Data are expressed as in C, and are from one of two independent experi-
ments. (F) MyD88-5 expression in mouse brain during development. 
E12-18, embryonic days after conception; P1-60, postnatal days. qRT-PCR 
results are normalized to GAPDH and shown as the percentage of 
MyD88-5 expression in adult brain.2066 MYD88-5 REGULATES NEURON SURVIVAL | Kim et al.
evenly in the cytoplasm, sparing the nuclei (  Fig. 3 C  , middle). 
In contrast, a construct consisting of only the TIR domain 
(TIR/GFP) distributed evenly throughout the cytoplasm and 
the nuclei (  Fig. 3 C  , bottom). Thus, HEAT/Armadillo repeats 
control the association of MyD88-5 with mitochondria, 
whereas either or both of the SAM domains and the TIR do-
main are required for mitochondrial clustering. 
  The apparent association of MyD88-5 with mitochon-
dria in transfected cells in vitro was confi  rmed biochemi-
cally in nontransfected cells in vivo by isolating mitochondrial 
fractions from mouse brain. MyD88-5 was found both in 
the mitochondrial fraction and in the soluble fraction (  Fig. 
3 D  ), which is consistent with the morphologic picture of 
a peripheral rather than integral association of MyD88-5 
with mitochondria. A peripheral association of MyD88-5 
with mitochondria might permit much of the protein to 
dissociate from mitochondria during the extensive isola-
tion procedure. 
  Likewise, the apparent morphologic association of MyD88-5 
with microtubules in transfected cells was confi  rmed biochem-
ically in nontransfected cells in vivo by isolating microtubule 
fractions from mouse brain. MyD88-5 cosedimented with 
  polymerized microtubules, but not when polymerization of 
tubulin was blocked by colchicine (  Fig. 3 E  ). 
which is consistent with the absence of a mitochondrial target-
ing sequence in MyD88-5. 
  The distribution and shape of mitochondria varied in 
COS-1 cells depending on their expression level of MyD88-5. 
In cells expressing a low to moderate level of MyD88-5, mito-
chondria were small, rod-shaped, and distributed widely through-
out the cytoplasm, as in untransfected cells (  Fig. 3 B  , top). 
In cells with high levels of MyD88-5 expression, mitochon-
dria were large, round, and clustered around the microtubule-
organizing center, being nearly absent from the periphery 
(  Fig. 3 B  , bottom). No changes were noted in the appear-
ance or distribution of other organelles, such as the Golgi 
apparatus or microtubules (  Fig. 3 A  ). Thus, overexpression of 
MyD88-5 may have disrupted the association of mitochondria 
with microtubules. 
  We then attempted to assign the mitochondria-binding and 
mitochondria-redistributing functions of MyD88-5 to specifi  c 
domains by transfecting COS-1 cells with constructs expressing 
truncated forms of MyD88-5. MyD88-5 lacking the two SAM 
domains and the TIR domain (Arm/GFP) localized to mito-
chondria, but did not make them cluster (  Fig. 3 C  , top). A small 
fraction of this mutant protein was also detected in nuclei. 
MyD88-5 lacking the HEAT/Armadillo repeats (     Arm/GFP) 
did not localize to mitochondria, but was instead distributed 
Figure 2.  Generation of transgenic mice expressing MyD88-5-GFP fusion protein and its expression in neurons in the brain. (A) Schematic of 
the MyD88-5 locus in BAC clone RP23-399H5, the targeting vector, and the predicted structure of the modifi  ed MyD88-5 locus. Exon numbers are 
indicated. Probe used for Southern blotting is shown in red. Restriction sites and predicted fragment sizes are indicated. The stop codon in exon 9 is 
removed, and GFP is introduced in-frame. (B) Representative Southern blot of restricted genomic DNA from transgenic (Tg) and nontransgenic mice. 
Transgene copy numbers shown below are calculated by comparing the intensity of the endogenous band (fi  lled arrowhead) and transgenic band 
(open arrowhead). (C) Expression of endogenous MyD88-5 and MyD88-5/GFP fusion protein in transgenic mouse brain. (left) Western blot with anti–
MyD88-5 antibody. (right) Western blot with anti-GFP antibody. The fusion protein has the expected molecular weight of 105 kD. (D) Widespread 
  expression of MyD88-5/GFP in the brain of transgenic mice. Brain sections from a nontransgenic mouse (left) and a transgenic (right) mouse were 
stained together with anti-GFP antibody. (E) Neuronal expression of MyD88-5/GFP. Fluorescent confocal microscopy captured direct GFP signals from 
unstained brain sections from a transgenic founder mouse. Right images are magnifi  cations of the insets from the left. Bars: (D) 1 mm; (E, left) 200  m; 
(E, right) 20  m.JEM VOL. 204, September 3, 2007 
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Figure 3.  Mitochondrial association of MyD88-5. (A) Selective colocalization of MyD88-5/GFP fusion protein with mitochondria and 
microtubules. COS-1 cells were transfected with a MyD88-5/GFP fusion construct. 18 h after the transfection, cells were stained with MitoTracker 
Red CMXRos for 20 min and fixed, or fixed, permeabilized, and stained with antibody for Golgi (anti– -adaptin) or microtubules (anti-tubulin). 
(B) Extrinsic association of MyD88-5 with mitochondria. Confocal microscopic images of COS-1 cells transfected with MyD88-5/GFP and stained 
with MitoTracker Red CMXRos. (top) Cells expressing lower levels of MyD88-5; (bottom) cells expressing higher levels of MyD88-5, with effects on 
mitochondrial shape and localization. (right) Magnifi  ed images of the boxed areas from the images on the left. (C) Analysis of domains of MyD88-5 
contributing to subcellular localization and mitochondrial association. COS-1 cells were transfected with the indicated constructs. 18 h later, mito-
chondria were stained with MitoTracker Red CMXRos before fi  xation. (D) Partial copurifi  cation of endogenous MyD88-5 and transgenic MyD88-5/GFP 
with mitochondria from brain. Mitochondria were isolated from wild type (non-Tg) or transgenic (Tg) mouse brains by differential centrifugation and 
lysates were Western blotted with antibody to MyD88-5 (top), GFP (middle), or TOM-23 (bottom). TOM-23 is an intrinsic mitochondrial membrane 
protein whose relative abundance serves as a loading control. (E) Copurification of endogenous MyD88-5 and microtubules from mouse brain. 
Microtubules were either polymerized with Taxol and GTP at 37 C or prevented from polymerization with colchicine at 4 C before purifi  cation by 
sucrose gradient centrifugation. Purifi  ed microtubule fractions (pellet), unpolymerized fractions (sup), and total brain lysate (total lysate) were Western 
blotted with antibody to MyD88-5. Bars, 10  m.2068 MYD88-5 REGULATES NEURON SURVIVAL | Kim et al.
decreasing the association of JNK3 with mitochondria would 
partially mimic JNK3 defi  ciency and protect neurons from 
death during deprivation of oxygen and glucose. 
  To test this hypothesis, we generated   Myd88-5    –  null mice 
using the strategy for homologous recombination depicted in 
  MyD88-5 associates with JNK3 and recruits it 
to the mitochondrial compartment 
  The InteractomeDB w15 database (http://vidal.dfci.harvard
.edu/interactomedb/i-View/) catalogs the results of a high-
throughput yeast two-hybrid screen used for systematic iden-
tifi  cation of protein  –  protein interactions in   C. elegans   (  35, 36  ). 
According to the database, the MyD88-5 worm homologue 
TIR-1 binds to at least seven proteins beside itself, most 
of which have mammalian homologues whose isoforms are 
expressed in brain. One is a homologue of JNK3 (MAPK10 
  isoform-3). We focused on the possibility that JNK3 may 
be a MyD88-5 binding partner because of the reported asso-
ciation of JNKs with mitochondria (  37  ) and microtubules 
(  38, 39  ). Interest in the candidacy of JNK3 was heightened 
further by its important role in regulating neuronal death 
during stress (  40  –  46  ). 
  Accordingly, we transfected COS-1 cells with a JNK3/red 
fl  uorescent protein (RFP) fusion protein. JNK3 localized 
mainly to the plasma membrane and cytoplasm (  Fig. 4 A  , 
middle).   When JNK3 was coexpressed with a MyD88-5/GFP 
fusion protein, the distribution of JNK3 changed dramatically; 
the majority of the protein appeared at the mitochondria (  Fig. 
4 A  , bottom). The redistribution was not caused by the RFP 
fusion tag, because RFP alone did not localize to mitochon-
dria when expressed with MyD88-5/GFP (  Fig. 4 A  , top). 
  The microscopic association of MyD88-5 with JNK3 was 
confi  rmed biochemically. MyD88-5 could be coimmuno-
precipitated with JNK3/GFP by anti-GFP antibody in COS-1 
cells cotransfected with MyD88-5 and JNK3/GFP fusion 
constructs (  Fig. 4 B  ). To confi  rm this association in a more 
physiologically relevant context, we sliced freshly isolated 
hippocampi into 150-     m-thick sections and exposed them to 
120 Joules/m  2   of UV light. We precipitated JNK3 and MyD88-5 
together from these hippocampal lysates with antibody against 
JNK3 (  Fig. 4 C  ). This association was more pronounced after 
UV irradiation, suggesting that MyD88-5 may be associated 
more avidly with activated JNK3. As a control, we used hippo-
campal slides from MyD88-5 knockout mice, whose genera-
tion is described in the next section. 
  Together, these data support the speculation that MyD88-5 
acts as a scaff  old not only to connect mitochondria to micro-
tubules but also to bring JNK3 to mitochondria. 
  Hippocampal neurons from MyD88-5  –  defi  cient mice are 
protected from death when deprived of oxygen and glucose 
  To probe the function of MyD88-5, we took a clue from its 
association with mitochondria and JNK3, both of which reg-
ulate apoptosis during cellular stress. One profound stress on 
the brain of major clinical signifi  cance is cerebral ischemia, 
which results in the deprivation of oxygen and glucose during 
vascular insuffi   ciency, such as cerebral stroke. With ischemia-
reperfusion injury, JNKs and BAD are increased in hippo-
campal neurons and translocate to the outer mitochondrial 
membrane (  40, 41  ). JNK3-null mice are protected from hippo-
campal cell death induced by cerebral ischemia (  43, 44  ). 
Thus, we hypothesized that genetic deletion of MyD88-5 by 
Figure 4.  MyD88-5–dependent recruitment of JNK3 to mitochondria. 
(A) Redistribution of JNK3 to mitochondria in the presence of MyD88-5. 
COS-1 cells were transfected with MyD88-5/GFP and RFP (top), GFP 
and JNK3/RFP (middle), or MyD88-5/GFP and JNK3/RFP (bottom). Mito-
chondria were stained with MitoTracker Red CMXRos. Bar, 10  m. 
(B) Co  immunoprecipitation of MyD88-5 with JNK3/GFP, but not with GFP 
alone, from transfected COS-1 cells. Immunoprecipitation was with anti-
GFP antibody and protein G–Sepharose and Western blotting was with 
antibody to MyD88-5 (top) or GFP (bottom). Open arrowhead indicates 
nonspecifi  c bands. (C) Coimmunoprecipitation of MyD88-5 with JNK3 in 
hippocampal slices from wild-type (WT) or MyD88-5 knockout (KO) mice. 
Half of the brain slices were preexposed to 120 Joules/m2 of UV light. 
Immunoprecipitation was done with anti-JNK1,3 and protein G–Sepharose 
and Western blot with anti-JNK3 and anti-MyD88-5.JEM VOL. 204, September 3, 2007 
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and microscopic levels revealed no abnormalities. In particular, 
the brains of MyD88-5  –  null mice appeared morphologically 
normal, as was the case for   JNK3  -null mice (  46  ). 
  A standard model for oxygen and glucose deprivation 
(OGD) uses hippocampal slices in vitro (  47  ), in which neuro-
nal viability is assessed by propidium iodide (PI) staining before 
and after OGD. In MyD88-5   /    and MyD88-5   /    mice, 
OGD induced massive cell death in the CA1 region of the 
  Fig. 5 A  .   Exons 3  –  6 were replaced with a neomycin resis-
tance gene in reverse orientation such that any read-through 
from exon 2  –  7 would be out of frame, precluding produc-
tion of a truncated form of MyD88-5. Production of wild-
type, hemizygous-defi  cient, and null mice was confi  rmed by 
Southern (  Fig. 5 B  ) and Western blot (  Fig. 5 C  ). Null pups 
were born at the expected Mendelian frequency from hemi-
zygous parents. Whole-body pathological evaluation at gross 
Figure 5.  Generation of MyD88-5 knockout mice and protection of their hippocampal neurons from OGD-induced cell death. (A) Schematic of 
the MyD88-5 locus, targeting vector, and predicted structure of the mutated locus. Exon numbers are indicated. The probe used for Southern blotting is 
shown in red. Restriction enzyme sites and predicted sizes of the digests are shown. Sp, SphI; Neo, neomycin resistance gene; DTX, diphtheria toxin gene. 
(B) Southern blot analysis of genomic DNA from MyD88-5 wild-type, hemizygous-defi  cient, and null mice. (C) Western blot analysis of MyD88-5 expression 
in wild-type, hemizygous-defi  cient, and null mice. 50  g of brain lysates were subjected to SDS-PAGE. Affi  nity-purifi  ed chicken anti–MyD88-5 antibody 
was used for detection. (D) Propidium iodide staining of dead neurons in hippocampal slices at the start of the OGD period (basal), after OGD (OGD), or the 
same period without OGD treatment (sham), and after exposure to 1 mM NMDA to induce a maximal cell death (Max). Hippocampi illustrated were from 
MyD88-5 /  (Het) or MyD88-5 /  mice (KO). Bar, 1 mm. (E) Quantitative evaluation of cell death after sham or OGD treatment in MyD88-5 /  (sham, n   6; 
OGD, n   13) MyD88-5 /  (sham, n   11; OGD, n   22) and MyD88-5 /  (sham, n   5; OGD, n   29) slices. P   0.05, Student’s t test.2070 MYD88-5 REGULATES NEURON SURVIVAL | Kim et al.
from specialized molecular machinery in neurons, the cell 
type in which mitochondria are likely to travel longer dis-
tances than in any other type of cell (  48  ). This interpretation 
is supported by the close resemblance of mitochondrial distri-
bution in our MyD88-5  –  overexpressing cells and in cells in 
which mitochondrial traffi   c along microtubules was disrupted 
via interference with the motor protein kinesin by gene-
tic disruption (  49  ) or TNF treatment (  50  ). Moreover, over-
expression of proteins involved in mitochondrial fi  ssion, 
fusion, and traffi   cking decreased mitochondrial movement, 
promoted a rounded rather than elongated mitochondrial mor-
phology and increased the cells  ’   susceptibility to apoptosis 
(  48, 51  –  57  ). 
  We also found that mouse MyD88-5, like its   C. elegans   
counterpart (  36  ), can bind JNK3. Moreover, mouse MyD88-5 
recruits JNK3 to mitochondria. This is consistent with the 
tendency of JNK pathway core components and their regula-
tors to form complexes that are targeted to intracellular or-
ganelles via scaff  olding proteins. 
  Diverse stresses, such as oxidative injury and infl  amma-
tory cytokines, induce activation (  58  ) and translocation of 
JNKs to mitochondria, where JNKs promote apoptosis (  37, 
59  ) by multiple mechanisms. JNK3 binds and inhibits the 
antiapoptotic proteins Bcl-2 (  60  ) and Bcl-xL (  37  ), mediates 
phosphorylation and oligomerization of the proapoptotic 
protein BAD (  61  ), and promotes translocation of the pro-
apoptotic protein BAX from the cytoplasm to mitochondria 
(  62  ). These actions may help account for JNK3  ’  s important 
role in stress-induced neuronal apoptosis and in the patho-
genesis of stroke and neurodegenerative diseases (  43, 45  ). 
During ischemia-reperfusion injury, CA1 hippocampal neu-
rons showed an increased level of activated JNKs and trans-
location of BAD to the outer mitochondrial membrane (  40, 41  ). 
During transient focal cerebral ischemia, the JNK pathway 
mediated Bax activation and induced neuronal apoptosis (  44  ). 
Conversely, overexpression of JNK-interacting protein-1 
sequestered JNKs in the cytosol, conferring protection against 
neuronal death induced by nerve growth factor withdrawal 
(  42  ). Targeted deletion of   Jnk3   protected mice from seizure 
and from death of hippocampal neurons induced by injec-
tion of a glutamate receptor agonist (  46  ). Cultured embry-
onic hippocampal neurons from   jnk3  -null mice retained 
cytochrome   c   inside the mitochondria after OGD, whereas 
wild-type cells showed diff  used cytochrome   c   staining (  43  ). 
Consistent with previous fi  ndings, MyD88-5 defi  ciency par-
tially protected hippocampal neurons from OGD-induced 
death. It will be of interest to test if MyD88-5 helps mediate 
neuronal fate decisions in response to infectious agents. 
  This study has identifi  ed an unexpected function of mam-
malian MyD88-5 in regulating neuron survival, probably via 
association with JNK3. However, there are likely to be addi-
tional partners and functions for MyD88-5. JNK3 is not 
known to be expressed in T cells, and its expression in rat 
brain has been demonstrated only in the pyramidal cells in the 
hippocampus and in the cortex (  63  ), as confi  rmed for pyrami-
dal cells in human brain (  64  ). MyD88-5 expression is broader. 
hippocampi (  Fig. 5, D and E  ). Compared with MyD88-5   /   , 
the cell death induced by OGD in the MyD88-5       /       hippo-
campi was reduced from 67.21       5.10 to 31.89       3.34% 
(P       0.05). 
  To test whether ablation of MyD88-5 aff  ects TLR-medi-
ated signaling pathways, we isolated bone marrow  –  derived 
macro  phages from MyD88-5  –  defi  cient mice and their wild-
type littermates. In response to LPS, poly IC, Pam3Cys, or CpG 
macrophages with or without an intact MyD88-5 gene ex-
pressed TNF and MCP-1 at comparable levels (Fig. S3, available 
at http://www.jem.org/cgi/content/full/jem.20070868/DC1). 
These results suggest that deletion of MyD88-5 neither enhances 
nor suppresses macrophage responses to stimuli that trigger 
TLR-2  –  4 or -9. 
    DISCUSSION   
  MyD88-5 is the only TIR-domain containing cytoplasmic 
protein conserved from worm to mammals and the only 
MyD88 family member found in   C. elegans  . The prominent 
contribution of all other known members of the MyD88 fam-
ily to innate immunity fueled the expectation that MyD88-5 
would play a similar role. However,   C. elegans    ’   MyD88-5 does 
not appear to mediate signaling from   C. elegans    ’   TLR (  16  ). 
Overexpression of human MyD88-5 failed to activate NF-     B  –   
or IFN-       –  regulated reporter genes (  17, 25  ). Carty et al. (  26  ) 
reported that MyD88-5 interacts with TRIF and negatively 
regulates TRIF-mediated LPS and poly(I:C) signaling path-
ways, and they detected what was interpreted as MyD88-5 in 
human PBMC by Western blot. However, we did not detect 
MyD88-5 mRNA or protein in myeloid cells from either 
human or mouse. Even in MyD88-5/GFP transgenic mice, 
where multiple copies of the transgene were expressed under 
MyD88-5  ’  s native promoter/enhancer, no GFP expression was 
detected in CD11b      macrophages (Fig. S2). In our hands, the 
commercial antibody used by Carty et al. (  26  ) detected recom-
binant MyD88-5, but also reacted in Western blots with a pro-
tein of similar apparent molecular weight whose abundance was 
unaff  ected by genetic ablation of MyD88-5 (Fig. S4, available 
at http://www.jem.org/cgi/content/full/jem.20070868/DC1). 
Macrophages from MyD88-5 knockout mice produced similar 
levels of TNF and MCP-1 as their wild-type counterparts in 
response to various TLR ligands, including LPS, poly(I:C), 
Pam3Cys, and CpG. Thus, in mouse, MyD88-5 does not have 
a nonredundant role in regulating macrophage responses to 
poly(I:C) and LPS. Our anti  –  MyD88-5 antibody does not pro-
duce a detectable signal in Western blots of LPS-treated human 
monocytes (unpublished data). 
  The highest expression of MyD88-5 was found in brain, 
which is consistent with the previous clue as to MyD88-5  ’  s 
function in the development of olfactory neurons in the 
worm (  18  ). Brain MyD88-5 was confi  ned to neurons, in 
which it was localized in part to mitochondria and micro-
tubules. Overexpression of MyD88-5 forced mitochondria to 
congregate at the microtubule-organizing center, raising the 
possibility that physiologic levels of MyD88-5 may regulate 
mitochondrial traffi   c along microtubules. This traffi   c may benefi  t JEM VOL. 204, September 3, 2007 
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clones selected with G418 were identifi  ed as positive for homologous re-
combination and used for injection into C57BL/6 blastocysts. Chimeras 
were identifi  ed and crossed with C57BL/6J for germline transmission. Ge-
nomic DNA prepared from tails was digested with SphI restriction enzyme 
for Southern analysis with a radiolabeled probe corresponding to exon 2. 
Transfection, selection, and screening of ES cells were done in the Gene 
Targeting Facility at The Rockefeller University. Pups with germline trans-
mission were intercrossed at Weill Medical College to generate mice with 
wild-type, heterozygous, or homozygous knockout alleles. 
  Generation of antibody to MyD88-5.     A full-length MyD88-5 cDNA 
was subcloned into Novagen  ’  s pET30b(+) for a fusion protein with hexahis-
tidine attached to its N terminus. BL21 (DE3) cells (2 liters) were trans-
formed with this plasmid and grown until the OD  600   reached 0.4. Protein 
expression was induced for 3 h with 1 mM isopropyl-(-D-thiogalactopyran-
oside), at which time most of the recombinant MyD88-5 was found in 
inclusion bodies. The bacterial pellet was lysed at room temperature for 
20 min with 100 ml of Tris buff  er (50 mM, pH 8.0) containing 100 mM NaCl, 
1 mM EDTA, and 1 mg/ml lysozyme, and centrifuged (500 g, 10 min). The 
pellets were purifi  ed further by resuspending in 50 ml of the same buff  er 
with 0.1% deoxycholate sodium salt. After 10 min of incubation on ice, 
8 mM MgCl  2   and 10   μ  g/ml DNase I were added to the samples for an addi-
tional 1 h. Samples were centrifuged again at 10,000   g   for 10 min at 4  °  C. 
The pellet was fi  rst washed with 50 ml of Tris buff  er (50 mM, pH 8.0) con-
taining 100 mM NaCl, 1 mM EDTA, and 1% NP-40, and then again with 
50 ml of Tris buff  er (50 mM, pH 8.0) with 1 M urea. The pellet was dis-
solved in the sample buff  er and run on a 9% SDS-PAGE gel. The protein 
band corresponding to MyD88-5, which was visualized by Coomassie stain-
ing, was cut out and the recombinant protein was eluted by a previously 
described method (  69  ). Recombinant MyD88-5 was concentrated with a 
Centricon column (10 kD cut-off  ; Millipore) and used for immunization 
of chickens to generate anti  –  mouse MyD88-5 fowl immunoglobulin (IgY). 
  Antibody was affi   nity purifi  ed by incubating 2 ml of purifi  ed IgY 
(27 mg/ml) with a nitrocellulose membrane (10 cm  2  ) on which 2 mg of puri-
fi  ed recombinant MyD88-5 had been blotted. After overnight incubation at 
4  °  C, the membrane was washed two times each with TBS and PBS for 5 min. 
Membrane-bound antibody was eluted twice with 100 mM glycine buff  er, 
pH 2.5, for 10 min. Eluted antibody was neutralized with 1 M Tris buff  er, 
pH 8.5, and stored in the presence of 5 mM sodium azide and 1 mg/ml BSA. 
  Transfection, immunoprecipitation, and immunoblot.     COS-1 cells 
cultured in 10-cm dishes at 80% confl  uency were transfected for 18 h with 
3      g of expression plasmids pJNK3/EGFP or pEGFP together with 3    g of 
pMyD88-5 with Lipofectamine 2000 (Sigma-Aldrich). Hippocampi were 
dissected from 8-wk-old C57BL/6 mice and coronal slices (thickness 150      M) 
were cut. Slices were transferred to Millicell CM membrane inserts (30 MM, 
0.4      m; Millipore) and the inserts were placed into 6-well plates containing 
0.5 ml culture medium (25% horse serum, 50% Eagle  ’  s basal medium, 
25% HBSS, 5 mg/ml glucose) in each well. Plates were exposed to ultra-
violet light in a cell culture hood for 1 min (    120 Joules/m  2  ). Hippocampal 
and cell lysates were prepared in 0.5 ml IP buff  er (PBS supplemented with 
5 mM EDTA, 0.5% Triton X-100, and protease inhibitors) and precleared 
with protein G beads (4  °  C for 1 h) for immunoprecipitation or boiled 
directly in Laemmli sample buff  er for immunoblot. Precleared lysates were 
incubated for 4 h with anti-GFP (BD Bioscience) or anti-JNK1,3 (eBio-
science) mixed with Protein G Sepharose (GE Healthcare) at 4  °  C. Washed 
beads were boiled in Laemmli buff  er. Proteins were separated by SDS-
PAGE, transferred onto a nitrocellulose membrane for immunoblotting with 
chicken anti  –  MyD88-5, mouse anti-GFP (Berkeley), or rabbit anti-JNK3 
(Millipore), and they were visualized with an enhanced chemiluminescence 
system (Millipore). 
  Epifl  uorescent and confocal microscopy.     COS-1 cells grown on cover-
slips in 12-well plates were transfected for 18 h with 400 ng of plasmids 
mixed with 0.8      l of Lipofectamine 2000 (Invitrogen). For mitochondrial 
It is possible that MyD88-5 may contribute to immunity in 
T lymphocytes, which are the only cells besides neurons in 
which we have been able to confi  rm its expression. 
    MATERIALS AND METHODS   
  Mice.     C57BL/6 (B6) mice were purchased from The Jackson Laboratory. 
Animal studies were approved by the Institutional Animal Care and Use 
Committee of Weill Medical College of Cornell University. 
  cDNA cloning.     The full-length or diff   erent domains of MyD88-5 or 
Jnk3     1 cDNA were cloned using RT-PCR from RNA prepared from the 
brain of a C57BL/6 mouse. A mammalian expression plasmid containing the 
full-length human MyD88-5 cDNA (pUNO-hSARM1a) was obtained 
from InvivoGen. GFP or RFP fusion proteins of MyD88-5 or JNK3 were 
generated by inserting individual cDNAs lacking stop codons upstream of 
fl  uorescent proteins in pEGFP-N1 (Clontech) or modifi  ed pDsRed-Express1 
(Clontech) with a CMV promoter. 
  Enrichment of mouse splenocyte subpopulations and human peri-
pheral blood leukocytes.     T or B cells were depleted from mouse spleno-
cytes using mouse Pan T or Pan B magnetic beads (Dynal). Human T or B 
cells were enriched from human peripheral blood with T or B cell negative 
isolation kits (Dynal). PMNs were separated from monocytes and lymphocytes 
by Polymorphprep (Axis-Shield PoC AS) according to the manufacturer  ’  s 
  instruction. The monocytes and lymphocytes were then separated by incubat-
ing the cells in a plastic dish for 2 h at 37     C. Floating cells were collected as a 
lymphocyte-enriched population, and adherent cells were washed and collected 
as a monocyte-enriched population. 
  Measurement of mRNA expression.     The ready to use tissue mRNA 
membrane (BALB/c male; Stratagene) was hybridized with a cDNA fragment 
corresponding to the two SAM domains and part of the TIR domain of 
MyD88-5 (1,200  –  1,816 bp). Quantitative RT-PCR was performed as previ-
ously described (  65  ). The probe and primer set sequences for mouse MyD88-5 are 
5     6-FAM d(AGCGGCTCGCAATTTTGTCCTGG) BHQ-1 3    ; 5    -GAC-
AAGCTTATCCAAAGCGTCA-3      and 5     -CGCCCCAGCAGACAGC-3     . 
The sequences for human MyD88-5 are 5     6-FAM d(CACCCGCAAGAG-
GTTCTTTAGGGAGC) BHQ-1 3     ; 5     -TGGGCATGAAATCGGGC-3      
and 5     -CGAAGGTCTTGAGCTCCGTG-3     . 
  Generation of   myd88-5  /GFP BAC transgenic mice.     MyD88-5/
GFP fusion transgenic mice were generated according the method of Gong 
et al. (  66  ). A pair of DNA fragments (527 and 377 bp), which was homol-
ogous to the fl  anking sequences of a site right before and after the MyD88-5 
stop codon, was inserted into a shuttle vector pLD53.SC-A-E-B (obtained 
from N. Heintz, The Rockefeller University, New York, NY) at the sites 
before and after a GFP gene. Integration of GFP into BAC was achieved by 
homologous recombination of the modifi  ed shuttle plasmid in a DH10 bac-
terial clone that harbors a BAC plasmid containing the C57BL/6J   myd88-5   
gene (RP23-399H5; Children  ’  s Hospital Oakland Research Institute). Modifi  ed 
BAC DNA was purifi   ed and injected into fertilized one-cell embryos 
(C57BL/6J       CBA/CA), which were then transplanted into pseudo  pregnant 
C57BL/6J female mice. Founder mice were identifi  ed by Southern blot 
  analyses using a probe corresponding to exon 9. The injections and the 
transplantations were done by The Transgenic Mouse Core Facility shared 
by Weill Medical College and Sloan Kettering Institute. 
  Targeted disruption of the   myd88-5   gene.     A 1,885-bp-long DNA frag-
ment for the left arm (SA) and a 6,880-bp-long DNA fragment for the right 
arm (LA) were PCR amplifi  ed from 129/SvJ mouse genomic DNA with an 
expanded 20 kb plus PCR system (Roche). The two arms were cloned with 
a PGK-neomycin cassette (  67  ) and a diphtheria toxin gene was added for 
negative selection (  68  ). The resulting construct was linearized at a unique 
XhoI enzyme site before transfection into 129/SvJ ES cells. 3 out of 192 2072 MYD88-5 REGULATES NEURON SURVIVAL | Kim et al.
containing 10 mM glucose and incubated in normoxic conditions. After 
OGD, the slices were transferred to normal culture medium containing PI 
and incubated for 24 h before fl  uorescence images were taken (F  OGD  ). The 
slices were treated with 100      M NMDA and PI for an additional 24 h, and 
images were captured for assessment of maximal fl  uorescence  intensity 
(F  max  ). Slices were imaged in the same order and orientation. The camera 
exposure settings were carefully adjusted so that F  basal   was detectable and 
F  max   did not saturate the camera. The same settings (exposure time, fi  lter 
setting, and gain) were used throughout the experiments. The percent-
age of cell death in CA1 was calculated with the formula (F  OGD         F  basal  )/
(F  max         F  basal  )       100. Two-group comparisons were analyzed by the two-tailed 
Student  ’  s   t   test for independent samples. P values  0.05 were considered 
statistically signifi  cant. 
  Online supplemental material.     Fig. S1 illustrates the domain organiza-
tion of MyD88-5 and its position in a phylogenic tree within the TIR do-
main superfamily. Fig. S2 indicates that GFP could not be detected by fl  ow 
cytometry in thymocytes or CD11b   splenocytes (macrophages) of   MyD88-5/
GFP   BAC transgenic mice. Fig. S3 shows that ablation of MyD88-5 has no 
eff  ect on macrophage responses to various TLR ligands. Fig. S4 shows that 
a commercial anti-SARM (MyD88-5) antibody recognizes a protein in or-
gans from MyD88-5 knockout mice.The online version of this article is 
available at http://www.jem.org/cgi/content/full/jem.20070868/DC1. 
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detection, cells were stained with 10 nM MitoTracker Red CMXRos 
(Invitrogen) for 20 min before fi  xation. For microtubule and Golgi detec-
tion, cells were fi  xed with ice-cold methanol for 10 min or 4% paraformal-
dehyde in PBS for 5 min at room temperature, followed by permeabilization 
with saponin (0.0375%). Fixed cells were stained with anti-tubulin (1:200; 
GE Healthcare) or anti  –       -adaptin antibody (1:100; BD Biosciences), fol-
lowed by Cy3-conjugated Fab fragment of donkey anti  –  mouse IgG (1:800; 
Jackson ImmunoResearch Laboratories) for detection of microtubules or 
Golgi, respectively. Nuclei were stained with 10 ng/ml DAPI. 
  Epifl  uorescent images were acquired using a digital camera (Coolpix 
5000; Nikon) attached to a fl  uorescent microscope (Bx60; Olympus) with a 
1,000      magnifi  cation lens and a 3      zoom lens on the camera. Confocal 
images were taken with a spectral confocal system (TCS SP2; Leica). The 
acoustooptical beam-splitter system and sequential image recording were 
used for image collection. The excitation intensities and spectral detection 
windows were systematically adjusted to optimize signals and avoid cross talk 
between channels. Single-channel excitation and dual-channel recording 
before data collection routinely confi  rmed the absence of cross talk between 
the channels. 
  Isolation of mitochondria and microtubules.     Mitochondria were iso-
lated from mouse brain using a method modifi  ed from Kang et al. (  70  ). In 
brief, 2 mouse brains were washed, minced in 5 ml of ice-cold Mito buff  er 
(10 mM Tris HCl, pH 7.8, plus 0.2 mM EDTA, 0.25 M sucrose, and protease 
inhibitors), and homogenized. Supernatant after centrifugation (800   g  , 10 min 
at 4  °  C) was collected and centrifuged again at 10,000   g   at 4  °  C for 10 min to 
enrich the mitochondrial fraction. The resulting pellet was resuspended in 
1 ml of the same buff  er and spun at 300   g   at 4  °  C for 5 min to remove bigger 
organelles. The supernatant was then collected and centrifuged at 10,000 g at 
4  °  C for 10 min to pellet the mitochondrial fraction. The pellet was washed 
once and resuspended with Mito buff  er for Western blot analysis. 
  Microtubule-associated proteins were isolated according to the method 
of Vallee et al. (  71  ). Brains from 10 mice were pooled and homogenized in 
7.5 ml of 0.1 M PEM buff  er (0.1 M Pepes, pH 6.9, with 1 mM EGTA and 
0.5 mM MgCl  2  ) supplemented with protease inhibitors at 4  °  C. After cen-
trifugation at 100,000   g   for 60 min at 4  °  C, supernatants were then divided 
into two aliquots. One aliquot was incubated at 37  °  C for 15 min with 20      M 
of Taxol and 1 mM of GTP to polymerize microtubules and the other ali-
quot was kept at 4 C with addition of 0.1 mM colchicine (negative control). 
Polymerized microtubules were isolated by centrifugation on a sucrose gra-
dient (10% sucrose, 30,000   g  , 30 min at 37 C). The pellet containing micro-
tubules and microtubule-binding proteins was rinsed with warm PEM buff  er 
and subjected to Western blot analysis. 
  Organotypic mouse hippocampal slice culture and OGD.     Hippo-
campi were dissected aseptically from 5  –  6-d-old   myd88-5     /    mice and 
their wild-type or hemizygous littermates, and 350-     M-thick coronal 
slices were cut using a McIlwain tissue chopper (Vibratome Company). 
Slices were transferred to Millicell CM membrane inserts (30 MM, 0.4      m; 
Millipore), and the inserts were placed into 6-well plates containing a 1-ml-
slice of culture medium (25% horse serum, 50% Eagle  ’  s basal medium, 25% 
HBSS, 5 mg/ml glucose) in each well. The cultures were maintained in a 
humidifi  ed chamber at 37 C with 5% CO  2   for 13 d, and the medium was 
changed twice a week. On day 13, slides were incubated in fresh medium 
containing the cell death marker PI (2.5      g/ml; Sigma-Aldrich). 1 d later, 
baseline fl  uorescence images (F  basal  ) were taken using a fl  uorescence mi-
croscope (Eclipse; Nikon) equipped with a digital camera (Retiga Exi; 
QImaging) connected to a computer (Macintosh) running IPLab software 
(Scanalytics, Inc.). Procedures for OGD and assessment of neuronal injury 
were as follows. Slices were placed in OGD buff  er (125 mM NaCl, 5 mM 
KCl, 1.2 mM Na  2  HPO  4  , 26 mM NaHCO  3  , 1.8 mM CaCl  2  , 0.9 mM 
MgCl  2  , and 10 mM Hepes, pH 7.4), transferred to an OGD chamber (Billups-
Rothenberg), and fl  ushed (21 liters/min for 5 min) with a gas mixture con-
taining 95% N  2   and 5% CO  2  . The chamber was sealed and placed into an 
incubator at 37 C for 1 h. Control slices were rinsed with OGD buff  er JEM VOL. 204, September 3, 2007 
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